Status:
COMPLETED
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
Lead Sponsor:
Sandoz
Conditions:
High Blood Pressure
Migraine Headaches
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
July 1 1994
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 1994
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00960245
Start Date
July 1 1994
End Date
July 1 1994
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.